Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jad Chahoud"'
Autor:
Irini Youssef, Aasha I. Hoogland, Jad Chahoud, Philippe E. Spiess, Heather Jim, Peter A.S. Johnstone
Publikováno v:
Urologic oncology. 40(9)
Patient reports of their symptom burden (i.e., patient-reported outcomes or PROs) have been shown to direct clinicians' ability to personalize care and improve outcomes. A disciplined assessment of PRO in the population of patients with advanced peni
Autor:
Jingsong Zhang, Logan Zemp, Scott M. Gilbert, Ali Hajiran, Wade J. Sexton, Rohit Jain, Roger Li, Nicholas H. Chakiryan, Lee A. Hugar, Brandon J. Manley, Jad Chahoud, Da David Jiang, Elizabeth Green, Kyle A. Gillis
Publikováno v:
Urologic oncology. 40(3)
Clinical trials have not shown a significant overall survival (OS) difference between chemotherapy and immunotherapy as first-line agents in metastatic urothelial carcinoma (UC). However, the generalizability of these findings in a real-world setting
Autor:
Amishi Yogesh Shah, Matthew T. Campbell, Kanishka Sircar, Padmanee Sharma, Surena F. Matin, Sangeeta Goswami, Pavlos Msaouel, Eric Jonasch, Lianchun Xiao, Barrett McCormick, Nizar M. Tannir, Jianjun Gao, Jeremy A. Ross, Jose A. Karam, Amado J. Zurita, Tharakeswara K. Bathala, Jad Chahoud, Robert Horn, Christopher G. Wood
Publikováno v:
Urologic oncology. 39(2)
Introduction Metastatic renal cell carcinoma with sarcomatoid dedifferentiation (sRCC) is associated with poor survival outcomes. We aimed to analyze the efficacy and safety of immune checkpoint inhibitors (ICI) in patients with sRCC comparing clear-
Autor:
Julio M. Pow-Sang, Ahmet M. Aydin, Ali Hajiran, Logan Zemp, Salim Cheryian, Jad Chahoud, Phillippe E. Spiess
Publikováno v:
Urologic oncology. 39(1)
Purpose The toxicity of topical chemotherapeutics has been well-characterized in extra-genital squamous cell carcinoma; however, there is limited data regarding the use of topical agents for penile squamous cell carcinoma in situ (CIS). We aim to des